Ireland
--:--IST
Recruiting Observational

Valvular Heart Disease Registry Study in Second Affiliated Hospital of ZheJiang University

NCT03011697 · tracked via the Priya Life Science China tracker
Phase
Observational
Started
2017-02-01
Last updated
2021-07-15

Condition(s) studied

Valvular Heart Disease

Study summary

We design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification,cost-effective ,treatments and prognosis of Chinese hospitalised adult patients with valvular heart disease.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Hospitalized patients over 18 years old meet one of the following conditions. 1. moderate or above valvular heart disease as defined by echocardiography: 1.1 Aortic stenosis, moderate or above, or valve area ≤1.5cm2, or maximal jet velocity ≥3.0m/sec, or mean pressure gradient ≥20mmHg, 1.2 Aortic regurgitation, moderate or above, or jet width ≥25% of left ventricular outflow tract, or regurgitant volume ≥30ml/beat, or regurgitant fraction ≥30%, 1.3 Mitral stenosis, moderate or above, or valve area ≤2.0cm2, 1.4 Mitral regurgitation, moderate or above, or effective regurgitant orifice ≥0.2cm2, or regurgitant volume ≥30ml/beat, or regurgitant fraction ≥30%, 1.5 Tricuspid stenosis, moderate or above, or valve area ≤1.0cm2, 1.6 Tricuspid regurgitation, moderate or above, or central jet area ≥5.0cm2, 1.7 Pulmonic stenosis, moderate or above, or maximal jet velocity \>4m/sec, 1.8 Pulmonic regurgitation, moderate or above, 2. Patients who had undergone any operation on a cardiac valve (percutaneous balloon commissurotomy, valve repair, valve replacement, transcatheter aortic valve implantation), 3. Diagnosis of endocarditis as assessed by Duke criteria. Exclusion Criteria: 1. Patients cannot be followed up for any reasons. 2. Patients in critical condition may be die in one year. 3. Patients have been enrolled in this study.

Primary outcome measure(s)

  • All-cause mortality and disabling strokes — one year
    All-cause mortality and disabling strokes

Trial sites (1)

FacilityCityRegionStatus
2nd Affiliated Hospital, School of Medicine at Zhejiang University Hangzhou Zhejiang Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03011697 on ClinicalTrials.gov ↗ ← All trials in China